🇮🇹 Italy Country × Condition
diffuse large b cell lymphoma Clinical Trials in Italy
Active clinical trials for diffuse large b cell lymphoma with research sites in Italy. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 1, Phase 2, Phase 1 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇮🇹 Italy
Active Trials in Italy (3)
NCT04300101
Recruiting
Mixed Molecular Clinical Index (MMCI) in Diffuse Large B-cell Lymphoma (DLBCL)
Enrollment
300 pts
Country
🇮🇹 Italy
Istituto Romagnolo per lo Studio de...
View Trial → NCT04104776 Phase 1, Phase 2
Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Enrollment
300 pts
Country
🇮🇹 Italy
Novartis Pharmaceuticals
View Trial → NCT05365659 Phase 1
Recruiting
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Enrollment
140 pts
Country
🇮🇹 Italy
Iksuda Therapeutics Ltd.
View Trial → Frequently Asked Questions
How many diffuse large b cell lymphoma clinical trials are active in Italy?
There are currently 3 active clinical trials for diffuse large b cell lymphoma with sites in Italy, of which 3 are actively recruiting patients.
How can I join a diffuse large b cell lymphoma clinical trial in Italy?
To join a diffuse large b cell lymphoma clinical trial in Italy, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Italy directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are diffuse large b cell lymphoma trials in Italy?
Active diffuse large b cell lymphoma trials in Italy span Phase 1, Phase 2, Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology